Mankind Pharma P/E Ratio

Current P/E Ratio
45.45
High Valuation
Very High - High growth expectations or significantly overvalued

Mankind Pharma P/E ratio. Mankind Pharma (MANKIND) P/E ratio is 45.45 (High), EPS (TTM) ₹46.35, current price ₹2275.60 on NSE vs historical average P/E of 46.23 (66.7th percentile) — Very High - High growth expectations or significantly overvalued. Also explore MANKIND stock price history to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 45.45
Current Price ₹2275.60
EPS (TTM) ₹46.35
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 46.23
Historical Range 32.98 - 66.85
Percentile 66.7%

Sector Context

Sector Average 54.88
Sector Median 31.69
Sector Rank #11 of 200
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹49.78
Mar 2026 ₹13.44
Jun 2026 ₹13.76

MANKIND P/E Ratio — Valuation Signal & Historical Context

Mankind Pharma P/E 45.45 vs historical average 46.23, range 32.98–66.85 — signal: Overvalued. Examine MANKIND quarterly trends for recent quarterly revenue, profit and EPS trends.

  • Stock appears overvalued with PE of 45.45, suggesting caution for new investments
  • Trading at discount to sector average PE of 54.88

Mankind Pharma P/E Ratio Historical Trend

MANKIND annual price-to-earnings ratio — 3 years, EPS and year-end price. Current P/E 45.45 vs historical average 46.23. For live price, revenue and the complete fundamental profile, see Mankind Pharma share price today.

MANKIND Historical P/E Ratio — EPS, Year-End Price & Valuation

Mankind Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 66.85 43.1 ₹2881.05 NSE High
2024 38.87 50.92 ₹1979.20 NSE High
2023 32.98 43.12 ₹1422.30 NSE High

MANKIND vs Healthcare Peers — P/E Ratio Comparison

Mankind Pharma P/E 45.45 vs Healthcare average 54.88, median 31.69 — range 2.02–722.21.

Sector Average
54.88
Sector Median
31.69
Lowest P/E
2.02
Highest P/E
722.21
Companies
200
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.02 ₹60 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.33 ₹55 Low
Sun Pharma Advanced Rese… SPARC 3.86 ₹6,006 Low
Dipna Pharmachem DPL 3.97 ₹11 Low
JFL Life Sciences JFLLIFE 5.05 ₹65 Low
Royal Sense ROYAL 5.39 ₹40 Low
Kabra Drugs KABRADG 5.47 ₹41 Low
GKB Ophthalmics GKB 5.85 ₹32 Low
Colinz Laboratories COLINZ 6.31 ₹18 Low